Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;85:1374-1379

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McMurray, J. J.
Right arrow Articles by Morton, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McMurray, J. J.
Right arrow Articles by Morton, J. J.

Circulation, Vol 85, 1374-1379, Copyright © 1992 by American Heart Association


ARTICLES

Plasma endothelin in chronic heart failure

JJ McMurray, SG Ray, I Abdullah, HJ Dargie and JJ Morton
Department of Cardiology, Western Infirmary, Glasgow, UK.

BACKGROUND. Endothelins are recently characterized vasoconstrictor peptides. As chronic heart failure (CHF) is characterized by peripheral arteriolar and renal vasoconstriction, we have measured venous plasma endothelin-like immunoreactivity ("endothelin") in patients with this syndrome. METHODS AND RESULTS. Compared with age- and sex-matched healthy volunteers (mean +/- SEM plasma endothelin concentration 6.4 +/- 0.3 pmol/l, n = 16), patients with severe CHF had elevated peripheral venous endothelin concentrations (12.4 +/- 0.6 pmol/l, n = 47, p less than 0.01). Plasma endothelin did not increase with exercise in normal subjects or in patients. Plasma endothelin concentration (mean, 13.4 +/- 0.9 pmol/l) did not correlate with plasma atrial natriuretic factor concentration (mean, 88.9 +/- 11.9 pg/ml) in patients with CHF (n = 21). There was also no correlation between plasma endothelin and serum urea or between endothelin and serum creatinine in patients with CHF (n = 34). There was, however, significant renal extraction of endothelin (aorta, 11.1 +/- 0.8 pmol/l; renal vein, 8.8 +/- 0.6 pmol/ml; p = 0.02) in patients with CHF (n = 13). CONCLUSIONS. Evidence suggests that circulatory endothelin concentrations in the range 5-40 pmol/l are vasoactive. Consequently, the endothelin concentrations found in patients with CHF may be of pathophysiological significance.


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
B. J Epstein
Efficacy and Safety of Darusentan: A Novel Endothelin Receptor Antagonist
Ann. Pharmacother., July 1, 2008; 42(7): 1060 - 1069.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Otani, F. Otsuka, K. Inagaki, J. Suzuki, T. Miyoshi, Y. Kano, J. Goto, T. Ogura, and H. Makino
Aldosterone Breakthrough Caused by Chronic Blockage of Angiotensin II Type 1 Receptors in Human Adrenocortical Cells: Possible Involvement of Bone Morphogenetic Protein-6 Actions
Endocrinology, June 1, 2008; 149(6): 2816 - 2825.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. B. Murray, J. D. Gardner, G. L. Brower, and J. S. Janicki
Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1251 - H1257.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. J. V. McMurray, J. R. Teerlink, G. Cotter, R. C. Bourge, J. G. F. Cleland, G. Jondeau, H. Krum, M. Metra, C. M. O'Connor, J. D. Parker, et al.
Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure: The VERITAS Randomized Controlled Trials
JAMA, November 7, 2007; 298(17): 2009 - 2019.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. W. Wray, S. K. Nishiyama, A. J. Donato, M. Sander, P. D. Wagner, and R. S. Richardson
Endothelin-1-mediated vasoconstriction at rest and during dynamic exercise in healthy humans
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2550 - H2556.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Gujic, A. Houssiere, O. Xhaet, J.-F. Argacha, N. Denewet, A. Noseda, P. Jespers, C. Melot, R. Naeije, and P. van de Borne
Does Endothelin Play a Role in Chemoreception During Acute Hypoxia in Normal Men?
Chest, May 1, 2007; 131(5): 1467 - 1472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Merkus, O. Sorop, B. Houweling, F. Boomsma, A. H. van den Meiracker, and D. J. Duncker
NO and prostanoids blunt endothelin-mediated coronary vasoconstrictor influence in exercising swine
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2075 - H2081.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. R. Schwarz, S. Rastogi, V. Kapur, N. Sulemanjee, and J. J. Rodriguez
Erectile Dysfunction in Heart Failure Patients
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1111 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. D. Jackson, K. Barnes, S. Homer-Vanniasinkam, and A. J. Turner
Expression and localization of human endothelin-converting enzyme-1 isoforms in symptomatic atherosclerotic disease and saphenous vein.
Experimental Biology and Medicine, June 1, 2006; 231(6): 794 - 801.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. Vetter, S. G. Shaw, R. P. Brandes, K. MuNter, W. Vetter, and M. Barton
Beneficial Cardiovascular Effects of Endothelin ETA Receptor Blockade in Established Long-Term Heart Failure After Myocardial Infarction.
Experimental Biology and Medicine, June 1, 2006; 231(6): 857 - 860.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. Maeda, S. Jesmin, M. Iemitsu, T. Otsuki, T. Matsuo, K. Ohkawara, Y. Nakata, K. Tanaka, K. Goto, and T. Miyauchi
Weight loss reduces plasma endothelin-1 concentration in obese men.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1044 - 1047.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Backs, E. Bresch, M. Lutz, A. V. Kristen, and M. Haass
Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats
Cardiovasc Res, August 1, 2005; 67(2): 283 - 290.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S J Leslie, J C S Spratt, S P McKee, F E Strachan, D E Newby, D B Northridge, M A Denvir, and D J Webb
Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure
Heart, July 1, 2005; 91(7): 914 - 919.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. B. Tanowitz, H. Huang, L. A. Jelicks, M. Chandra, M. L. Loredo, L. M. Weiss, S. M. Factor, V. Shtutin, S. Mukherjee, R. N. Kitsis, et al.
Role of Endothelin 1 in the Pathogenesis of Chronic Chagasic Heart Disease
Infect. Immun., April 1, 2005; 73(4): 2496 - 2503.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. B. Murray, J. D. Gardner, G. L. Brower, and J. S. Janicki
Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2295 - H2299.
[Abstract] [Full Text] [PDF]


Home page
Fam PractHome page
J. E Tisdale, M. B Huang, and S. Borzak
Risk factors for hypertensive crisis: importance of out-patient blood pressure control
Fam. Pract., August 1, 2004; 21(4): 420 - 424.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. G von Lueder, H. Kjekshus, T. Edvardsen, E. Oie, S. Urheim, L. E. Vinge, M. S. Ahmed, O. A Smiseth, and H. Attramadal
Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1
Cardiovasc Res, July 1, 2004; 63(1): 41 - 50.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Motte, R. van Beneden, J. Mottet, B. Rondelet, M. Mathieu, X. Havaux, P. Lause, C. Clercx, J.-M. Ketelslegers, R. Naeije, et al.
Early activation of cardiac and renal endothelin systems in experimental heart failure
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2482 - H2491.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. M Tovar and J. G Gums
Tezosentan in the Treatment of Acute Heart Failure
Ann. Pharmacother., December 1, 2003; 37(12): 1877 - 1883.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
D B McKenzie and A J Cowley
Drug therapy in chronic heart failure
Postgrad. Med. J., November 1, 2003; 79(937): 634 - 642.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Gattenlohner, C. Waller, G. Ertl, B.-D. Bultmann, H.-K. Muller-Hermelink, and A. Marx
NCAM(CD56) and RUNX1(AML1) Are Up-Regulated in Human Ischemic Cardiomyopathy and a Rat Model of Chronic Cardiac Ischemia
Am. J. Pathol., September 1, 2003; 163(3): 1081 - 1090.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Maeda, T. Tanabe, T. Miyauchi, T. Otsuki, J. Sugawara, M. Iemitsu, S. Kuno, R. Ajisaka, I. Yamaguchi, and M. Matsuda
Aerobic exercise training reduces plasma endothelin-1 concentration in older women
J Appl Physiol, July 1, 2003; 95(1): 336 - 341.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Godecke, A. Molojavyi, J. Heger, U. Flogel, Z. Ding, C. Jacoby, and J. Schrader
Myoglobin Protects the Heart from Inducible Nitric-oxide Synthase (iNOS)-mediated Nitrosative Stress
J. Biol. Chem., June 6, 2003; 278(24): 21761 - 21766.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Chu, R. Takahashi, I. Norota, T. Miyamoto, Y. Takeishi, K. Ishii, I. Kubota, and M. Endoh
Signal Transduction and Ca2+ Signaling in Contractile Regulation Induced by Crosstalk Between Endothelin-1 and Norepinephrine in Dog Ventricular Myocardium
Circ. Res., May 16, 2003; 92(9): 1024 - 1032.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Ogata, M. Takahashi, S. Ueno, K. Takeuchi, T. Okada, H. Mano, S. Ookawara, K. Ozawa, B. C. Berk, U. Ikeda, et al.
Antiapoptotic Effect of Endothelin-1 in Rat Cardiomyocytes In Vitro
Hypertension, May 1, 2003; 41(5): 1156 - 1163.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. L. Pina, C. S. Apstein, G. J. Balady, R. Belardinelli, B. R. Chaitman, B. D. Duscha, B. J. Fletcher, J. L. Fleg, J. N. Myers, and M. J. Sullivan
Exercise and Heart Failure: A Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention
Circulation, March 4, 2003; 107(8): 1210 - 1225.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Kaluski, I. Kobrin, R. Zimlichman, A. Marmor, O. Krakov, O. Milo, A. Frey, S. Kaplan, R. Krakover, A. Caspi, et al.
RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema: A prospective, multicenter, double-blind, placebo-controlled study
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 204 - 210.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. F. Luscher, F. Enseleit, R. Pacher, V. Mitrovic, M. R. Schulze, R. Willenbrock, R. Dietz, V. Rousson, D. Hurlimann, S. Philipp, et al.
Hemodynamic and Neurohumoral Effects of Selective Endothelin A (ETA) Receptor Blockade in Chronic Heart Failure: The Heart Failure ETA Receptor Blockade Trial (HEAT)
Circulation, November 19, 2002; 106(21): 2666 - 2672.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J J V McMurray
Heart failure in 10 years time: focus on pharmacological treatment
Heart, October 1, 2002; 88(90002): ii40 - 46.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Johnson, A. Nohria, L. Garrett, J. C. Fang, J. Igo, M. Katai, P. Ganz, and M. A. Creager
Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H568 - H575.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Matsumoto, H. Aihara, R. Yamauchi-Kohno, Y. Reien, T. Ogura, H. Yabana, Y. Masuda, T. Sato, I. Komuro, and H. Nakaya
Long-Term Endothelin A Receptor Blockade Inhibits Electrical Remodeling in Cardiomyopathic Hamsters
Circulation, July 30, 2002; 106(5): 613 - 619.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Ceconi, R. Ferrari, T. Bachetti, C. Opasich, M. Volterrani, B. Colombo, G. Parrinello, and A. Corti
Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality
Eur. Heart J., June 2, 2002; 23(12): 967 - 974.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. Johnson, T. Omland, C. Hall, C. Lucas, O. L. Myking, C. Collins, M. Pfeffer, J.-L. Rouleau, and L. W. Stevenson
Neurohormonal activation rapidly decreases after intravenous therapy withdiuretics and vasodilators for class IV heart failure
J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1623 - 1629.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
Z. Alioglu, A. Orem, I. Bulbul, C. Boz, M. Ozmenoglu, and B. Vanizor
Evaluation of Plasma Endothelin-1 Levels in Patients with Cerebral Infarction
Angiology, January 1, 2002; 53(1): 77 - 82.
[Abstract] [PDF]


Home page
Eur Heart JHome page
P.J. Cowburn and J.G.F. Cleland
Endothelin antagonists for chronic heart failure: do they have a role?
Eur. Heart J., October 1, 2001; 22(19): 1772 - 1784.
[PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Tadano, J. Suzuki, K. Hanada, M. Nakao, R. Nakao, S. Uehara, H. Ohta, T. Miyauchi, and M. Nishikibe
Pathophysiological Roles of Endogenous Endothelin-1 in Dogs with Chronic Heart Failure Produced by Rapid Right Ventricular Pacing
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 729 - 736.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. K. A. Witte, A. L. Clark, and J. G. F. Cleland
Chronic heart failure and micronutrients
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1765 - 1774.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. E. Spieker, G. Noll, F. T. Ruschitzka, and T. F. Luscher
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1493 - 1505.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-P. Cheng, T. Ukai, K. Onishi, N. Ohte, M. Suzuki, Z.-S. Zhang, H.-J. Cheng, H. Tachibana, A. Igawa, and W. C. Little
The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1853 - H1860.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. F. Luscher and M. Barton
Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs
Circulation, November 7, 2000; 102(19): 2434 - 2440.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. A. Walker, S. C. Baicu, A. T. Goldberg, C. E. Widener, D. J. Fary, D. K. Almany, A. Ergul, F. A. Crawford Jr, and F. G. Spinale
Temporal endothelin dynamics of the myocardial interstitium and systemic circulation in cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., November 1, 2000; 120(5): 864 - 871.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-T. Shen, P. S Buie, J. J Lynch, S. M Krause, and X.-L. Ma
Chronic therapy with an ETA/B receptor antagonist in conscious dogs during progression of congestive heart failure: Intracellular Ca2+ regulation and nitric oxide mediated coronary relaxation
Cardiovasc Res, November 1, 2000; 48(2): 332 - 345.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Zolk and M. Bohm
The role of the cardiac endothelin system in heart failure
Nephrol. Dial. Transplant., June 1, 2000; 15(6): 758 - 760.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. E. Spieker, V. Mitrovic, G. Noll, R. Pacher, M. R. Schulze, J.o. Muntwyler, C. Schalcher, W. Kiowski, T. F. Luscher, and on behalf of the ET 003 Investigators
Acute hemodynamic and neurohumoral effects of selective ETA receptor blockade in patients with congestive heart failure
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1745 - 1752.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C Berry and A.L Clark
Catabolism in chronic heart failure
Eur. Heart J., April 1, 2000; 21(7): 521 - 532.
[PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Kjekshus, O. A. Smiseth, R. Klinge, E. Oie, M. E. Hystad, and H. Attramadal
Regulation of ET: pulmonary release of ET contributes to increased plasma ET levels and vasoconstriction in CHF
Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1299 - H1310.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. N. Cohn, R. Ferrari, N. Sharpe, and on Behalf of an International Forum on Cardiac Rem
Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
J. Am. Coll. Cardiol., March 1, 2000; 35(3): 569 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. A. Walker, F. A. Crawford Jr, and F. G. Spinale
MYOCYTE CONTRACTILE DYSFUNCTION WITH HYPERTROPHY AND FAILURE: RELEVANCE TO CARDIAC SURGERY
J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 388 - 400.
[Full Text] [PDF]


Home page
CirculationHome page
P. A. MacCarthy, R. Grocott-Mason, B. D. Prendergast, and A. M. Shah
Contrasting Inotropic Effects of Endogenous Endothelin in the Normal and Failing Human Heart : Studies With an Intracoronary ETA Receptor Antagonist
Circulation, January 18, 2000; 101(2): 142 - 147.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Becker, B. Merkely, A. Bauer, L. Geller, L. Fazekas, K. D. Freigang, F. Voss, J. C. Senges, W. Kuebler, and W. Schoels
Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three-dimensional mapping
Cardiovasc Res, January 14, 2000; 45(2): 310 - 320.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. E. Negrao, M. A. Hamilton, G. C. Fonarow, A. Hage, J. D. Moriguchi, and H. R. Middlekauff
Impaired endothelium-mediated vasodilation is not the principal cause of vasoconstriction in heart failure
Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H168 - H174.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Brunner
Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat
Cardiovasc Res, October 1, 1999; 44(1): 197 - 206.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
S. Battistelli, M. Billi, G. Manasse, A. Vittoria, F. Roviello, and S. Forconi
Behavior of Circulating Endothelin-1 in a Group of Patients with Acute Myocardial Infarction
Angiology, August 1, 1999; 50(8): 629 - 638.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
M. Malmsjo, A. Bergdahl, X.-H. Zhao, X.-Y. Sun, T. Hedner, L. Edvinsson, and D. Erlinge
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure
Cardiovasc Res, July 1, 1999; 43(1): 200 - 209.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Bajoria, M. Sullivan, and N. M. Fisk
Endothelin concentrations in monochorionic twins with severe twin–twin transfusion syndrome
Hum. Reprod., June 1, 1999; 14(6): 1614 - 1618.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
O. Zolk, J. Quattek, G. Sitzler, T. Schrader, G. Nickenig, P. Schnabel, K. Shimada, M. Takahashi, and M. Bohm
Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure
Circulation, April 27, 1999; 99(16): 2118 - 2123.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Pieske, B. Beyermann, V. Breu, B. M. Loffler, K. Schlotthauer, L. S. Maier, S. Schmidt-Schweda, H. Just, and G. Hasenfuss
Functional Effects of Endothelin and Regulation of Endothelin Receptors in Isolated Human Nonfailing and Failing Myocardium
Circulation, April 13, 1999; 99(14): 1802 - 1809.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. D. Parker, J. J. Thiessen, R. Reilly, J. H. Tong, D. J. Stewart, and A. S. Pandey
Human Endothelin-1 Clearance Kinetics Revealed by a Radiotracer Technique
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 261 - 265.
[Abstract] [Full Text]